Firm Assists in Increasing Access to Biosimilars for Ukrainian Patients

  • Life Sciences

The Team advised and represented a global pharmaceutical and biotech giant on the complex issue of obtaining marketing authorization in Ukraine for its highly in-demand biosimilar product. Despite significant imperfections in the regulation of biosimilars in Ukraine, Marchenko Danevych’s lawyersassisted the Client with the development and implementation of a regulation improvement strategy.

This site uses cookies. An explanation of their purpose can be found within Terms of Use